Pinpointing a tell-tale mark of liver cancer

July 8, 2011
Individuals who carry a specific genetic variant and become infected with the hepatitis C virus could be susceptible to developing liver cancer. Credit: 2011 iStockphoto/Eraxion

Persistent hepatitis C virus (HCV) infection can lead to chronic hepatitis C and then progress to fatal liver diseases including liver cirrhosis and liver cancer, the third most common cause of cancer-related deaths. Worldwide, more than 170 million people are infected with HCV, and the virus accounts for 30–70% of liver cancer cases. The recent identification of a genetic variant associated with increased susceptibility to hepatitis C virus-induced liver cancer could have major implications for global healthcare, as it may lead to tests that predict liver cancer susceptibility.

Michiaki Kubo of the RIKEN Center for Genomic Medicine and colleagues from RIKEN and The University of Tokyo discovered the variant by analyzing the entire genomes of 721 Japanese individuals with HCV-induced and comparing them with those of 2,890 HCV-negative controls. This allowed them to identify variants potentially associated HCV-induced liver cancer (Fig. 1). They confirmed the association of one variant by replicating the study in another 673 liver cancer patients and 2,596 controls.

This variant was located within a region on chromosome 6, which contains many genes that are critical for immune system function. It lies between the genes encoding MICA, a membrane protein that activates the anti-tumor effects of white blood cells, and the HLA-B gene, which encodes a peptide that enables the immune system to distinguish between the body’s own proteins and those produced by invading microbes.

The researchers checked the variant in another 1,730 individuals with who had not developed liver cirrhosis or liver cancer, and revealed that it was significantly associated with progression from chronic hepatitis C to liver cancer, but not with susceptibility to chronic hepatitis C.

Finally, Kubo and colleagues examined MICA protein levels in patients with chronic hepatitis C and HCV-induced , and found that the level of MICA in blood samples was elevated during early stages of the disease compared to healthy controls. They also found that the identified variant was correlated with low MICA levels in patients with chronic hepatitis C.

These findings suggest that individuals carrying the genetic variant would express low levels of MICA. This in turn would lead to reduced response by white blood cells to cells infected with viruses, increasing the likelihood of progression from chronic hepatitis C to liver cancer.

“Our results suggest that low serum MICA levels are a marker for higher susceptibility to progression of liver cancer in the patients with chronic hepatitis C,” says Kubo.

Explore further: Coffee drinking improves hepatitis C treatment response

More information: Kumar, V., et al. Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma. Nature Genetics 43, 455–458 (2011).

Related Stories

Coffee drinking improves hepatitis C treatment response

June 7, 2011
Advanced hepatitis C patients with chronic liver disease may benefit from drinking coffee during treatment, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association ...

Genetic variant linked to development of liver cancer in hepatitis C virus carriers

July 3, 2011
A genome-wide study by researchers at the RIKEN Center for Genomic Medicine, Hiroshima University Hospital and Sapporo-Kosei General Hospital has identified a genetic variant associated with the development of liver cancer ...

Recommended for you

Scientists provide insight into genetic basis of neuropsychiatric disorders

July 21, 2017
A study by scientists at the Children's Medical Center Research Institute at UT Southwestern (CRI) is providing insight into the genetic basis of neuropsychiatric disorders. In this research, the first mouse model of a mutation ...

Scientists identify new way cells turn off genes

July 19, 2017
Cells have more than one trick up their sleeve for controlling certain genes that regulate fetal growth and development.

South Asian genomes could be boon for disease research, scientists say

July 18, 2017
The Indian subcontinent's massive population is nearing 1.5 billion according to recent accounts. But that population is far from monolithic; it's made up of nearly 5,000 well-defined sub-groups, making the region one of ...

Mutant yeast reveals details of the aberrant genomic machinery of children's high-grade gliomas

July 18, 2017
St. Jude Children's Research Hospital biologists have used engineered yeast cells to discover how a mutation that is frequently found in pediatric brain tumor high-grade glioma triggers a cascade of genomic malfunctions.

Late-breaking mutations may play an important role in autism

July 17, 2017
A study of nearly 6,000 families, combining three genetic sequencing technologies, finds that mutations that occur after conception play an important role in autism. A team led by investigators at Boston Children's Hospital ...

Newly identified genetic marker may help detect high-risk flu patients

July 17, 2017
Researchers have discovered an inherited genetic variation that may help identify patients at elevated risk for severe, potentially fatal influenza infections. The scientists have also linked the gene variant to a mechanism ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.